OncoKB: A Precision Oncology Knowledge BaseDebyani Chakravarty, Nikolaus Schultz, Jianjiong Gao et al.|JCO Precision Oncology|2017Cited by 2.7k
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Samuel Singer, Kinjal Shah et al.|Nature Genetics|2010Cited by 725
Abstract A35: A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcomaNeerav Shukla, Marc Ladanyi, Shinji Kohsaka et al.|Cancer Research|2014Cited by 1